Overview

Duobrii in Combination With Biologics

Status:
Recruiting
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
12 weeks DUOBRII to patients with 2%-10% BSA who are receiving biologic therapy for at least 24 weeks
Phase:
Phase 4
Details
Lead Sponsor:
Psoriasis Treatment Center of Central New Jersey
Collaborator:
Ortho Dermatologics